Publications by authors named "Christine Ravot"
This study describes characteristics, toxicity and survival in old patients with HR+/HER2-breast cancer (BC) treated with CDK4/6 inhibitors. Retrospective observational study that included patients ≥ 75 years with HR+/HER2-BC treated with CDK4/6 inhibitors between 2017 and 2021. Patients' general and cancer-related data were collected.
View Article and Find Full Text PDF(1) Background: The aging of the population, the increase in the incidence of cancer with age, and effective chronic oncological treatments all lead to an increased prevalence of cancer in nursing homes. The aim of the present study was to map the cultural and ethical barriers associated with the treatment of cancer and educational strategies in this setting. (2) Methods: A systematic scoping review was conducted until April 2021 in MEDLINE, Embase, and CINAHL.
View Article and Find Full Text PDFArticle Synopsis
- The study, Senior-COVID-Rea, aims to evaluate how age and various health parameters affect mortality within 30 days for COVID-19 patients over 60 years old admitted to ICUs.
- Conducted in seven hospitals in the Auvergne-Rhône-Alpes region of France, it will collect data on patients’ health and nutritional status before infection, alongside clinical parameters during their ICU stay.
- The primary goal is to identify predictive factors for mortality using statistical methods, aiding clinicians in making better admission decisions for older patients with severe COVID-19.
Background: Ageing is associated with an increased prevalence of comorbidities and sarcopenia as well as a decline of functional reserve of multiple organ systems, which may lead, in the context of the disease-related and/or treatment-related stress, to functional deconditioning. The multicomponent 'Prehabilitation & Rehabilitation in Oncogeriatrics: Adaptation to Deconditioning risk and Accompaniment of Patients' Trajectories (PROADAPT)' intervention was developed multiprofessionally to implement prehabilitation in older patients with cancer.
Methods: The PROADAPT pilot study is an interventional, non-comparative, prospective, multicentre study.
Introduction: A patient education program has been developed in the field of cancer for supporting cancer patients undergoing oral anticancer therapies. Its implementation was tested in 3 different settings. The objectives of this study were to 1) identify barriers and facilitators for implementing the patient education program, 2) identify practices encouraging or hindering implementation and 3) produce recommendations for its dissemination.
View Article and Find Full Text PDFThe concept of prehabilitation emerged in the United States in the 1940s to maintain the performance of American soldiers notably through good nutrition and sport. It was then a question of optimising the patient's health status in a pre-treatment situation and reducing surgical stress. The specific collaborative programme Proadapt, comprising multiprofessional expertise, was put in place for elderly patients in 2016.
View Article and Find Full Text PDFObjective: When treated with anticancer therapies, a number of issues are raised for older patients such as physical needs (coping with symptoms and side-effects) or psychological needs. Geriatric tailored interventions addressing these needs may be effective in terms of improving quality of life of our patients.
Methods: A systematic review was performed in September 2017 in MEDLINE.